297 related articles for article (PubMed ID: 24994626)
1. Intellectual property. Biotech feels a chill from changing U.S. patent rules.
Servick K
Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626
[No Abstract] [Full Text] [Related]
2. Intellectual property. Supreme Court rules out patents on 'natural' genes.
Marshall E
Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
[No Abstract] [Full Text] [Related]
3. Supreme Court boosts licensees in biotech patent battles.
Waltz E
Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
[No Abstract] [Full Text] [Related]
4. Genes can't be patented, rules Supreme Court.
McCarthy M
BMJ; 2013 Jun; 346():f3907. PubMed ID: 23771229
[No Abstract] [Full Text] [Related]
5. Patents. U.S. Supreme Court delves into what is and isn't patentable.
Marshall E
Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
[No Abstract] [Full Text] [Related]
6. Biotech patents: looking backward while moving forward.
Eisenberg RS
Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
[No Abstract] [Full Text] [Related]
7. Intellectual Property in Genetic Material.
Gatley I
J Bioeth Inq; 2015 Dec; 12(4):561-4. PubMed ID: 26691916
[No Abstract] [Full Text] [Related]
8. Antibody-patent row could have far-reaching impact on biotech.
Ledford H
Nature; 2023 Apr; 616(7955):17. PubMed ID: 36977755
[No Abstract] [Full Text] [Related]
9. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
Teitelbaum R; Cohen M
Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
[No Abstract] [Full Text] [Related]
10. Intellectual property. Court tightens patent rules on gene tags.
Kintisch E
Science; 2005 Sep; 309(5742):1797-9. PubMed ID: 16166482
[No Abstract] [Full Text] [Related]
11. US Supreme Court rules on landmark gene patent case.
Sklan A
Pharm Pat Anal; 2013 Sep; 2(5):581. PubMed ID: 24237164
[No Abstract] [Full Text] [Related]
12. US Supreme Court applies strict limits to patents.
Robertson D
Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
[No Abstract] [Full Text] [Related]
13. Intellectual property. What good is a patent? Supreme Court may suggest an answer.
Kintisch E
Science; 2006 Feb; 311(5763):946-7. PubMed ID: 16484470
[No Abstract] [Full Text] [Related]
14. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
Garber K
Science; 2006 May; 312(5775):827. PubMed ID: 16690824
[No Abstract] [Full Text] [Related]
15. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
Furrow ME
Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
[No Abstract] [Full Text] [Related]
16. Patents. Signature on visitor's form fuels Stanford v. Roche court battle.
Marshall E
Science; 2011 Apr; 332(6026):163. PubMed ID: 21474725
[No Abstract] [Full Text] [Related]
17. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
Palombi L
Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
[No Abstract] [Full Text] [Related]
18. US Supreme Court decision could compromise biotech patents.
Robertson D
Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
[No Abstract] [Full Text] [Related]
19. Patentability of Stem Cells in the United States.
Fendrick SE; Zuhn DL
Cold Spring Harb Perspect Med; 2015 Aug; 5(12):. PubMed ID: 26292987
[TBL] [Abstract][Full Text] [Related]
20. Biotechnology patents under fire.
Royzman I
Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
